发明名称 |
Compounds, compositions and methods for reducing toxicity and treating or preventing diseases |
摘要 |
The present invention provides compounds of Formula (I), compositions comprising an effective amount of a compound of Formula (I), optionally with chemotherapeutic drugs such as a tubulin-binding drug, and methods of their use for reducing the toxicity of cytotoxic agents, treating or preventing cancer or a neuropathic disorder, inducing a chemoprotective phase II enzyme, DNA, or protein synthesis, enhancing the immune system, treating inflammation, improving and enhancing general health or well-being, and methods for making compounds of Formula (I).; |
申请公布号 |
US8859615(B2) |
申请公布日期 |
2014.10.14 |
申请号 |
US200913061508 |
申请日期 |
2009.08.27 |
申请人 |
|
发明人 |
Danishefsky Samuel J.;Chou Ting-Chao;Lei Xiaoguang;Yun Heedong;Ng Fay;Hartung John;Sames Dalibor |
分类号 |
A61K31/191;A61K31/357;C07C31/22;C07D317/12;C07C33/048;A61K31/047;A61K31/075;A61K31/165;A61K31/196;A61K31/337;A61K31/343;A61K31/4192;A61K31/427;A61K31/661;A61K31/675;A61K31/7048;A61K45/06;C07C33/05;C07C33/14;C07C33/30;C07C43/315;C07C49/24;C07D249/04;C07D317/16;C07D317/18;C07D317/20;C07D317/22;C07D317/24;C07D317/26;C07D317/28;C07D317/30 |
主分类号 |
A61K31/191 |
代理机构 |
Ostrolenk Faber LLP |
代理人 |
Ostrolenk Faber LLP |
主权项 |
1. A compound of the Formula wherein: each R1 is independently —H; each R2 is independently —H, —C1-C6 alkyl, or —C(O)—C1-C6 alkyl, or both R2 groups combine to form —C(O)— or —C(Ra)(Ra)—, wherein each Ra is independently —H, —C1-C6 alkyl or phenyl; R3 is —H; and Z is —C1-C10 alkyl;or a pharmaceutically acceptable salt, solvate or hydrate thereof. |
地址 |
|